ID A0A0R3RPP0_9BILA Unreviewed; 1616 AA.
AC A0A0R3RPP0;
DT 20-JAN-2016, integrated into UniProtKB/TrEMBL.
DT 20-JAN-2016, sequence version 1.
DT 27-MAR-2024, entry version 34.
DE SubName: Full=Hemicentin-1 {ECO:0000313|WBParaSite:EEL_0000356901-mRNA-1};
OS Elaeophora elaphi.
OC Eukaryota; Metazoa; Ecdysozoa; Nematoda; Chromadorea; Rhabditida;
OC Spirurina; Spiruromorpha; Filarioidea; Onchocercidae; Elaeophora.
OX NCBI_TaxID=1147741 {ECO:0000313|Proteomes:UP000050640, ECO:0000313|WBParaSite:EEL_0000356901-mRNA-1};
RN [1] {ECO:0000313|WBParaSite:EEL_0000356901-mRNA-1}
RP IDENTIFICATION.
RG WormBaseParasite;
RL Submitted (FEB-2017) to UniProtKB.
CC -!- CAUTION: Lacks conserved residue(s) required for the propagation of
CC feature annotation. {ECO:0000256|PROSITE-ProRule:PRU00076}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR STRING; 1147741.A0A0R3RPP0; -.
DR WBParaSite; EEL_0000356901-mRNA-1; EEL_0000356901-mRNA-1; EEL_0000356901.
DR Proteomes; UP000050640; Unplaced.
DR GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR CDD; cd00054; EGF_CA; 5.
DR CDD; cd00096; Ig; 2.
DR Gene3D; 2.40.155.10; Green fluorescent protein; 1.
DR Gene3D; 2.60.40.10; Immunoglobulins; 10.
DR Gene3D; 2.10.25.10; Laminin; 5.
DR InterPro; IPR026823; cEGF.
DR InterPro; IPR001881; EGF-like_Ca-bd_dom.
DR InterPro; IPR000742; EGF-like_dom.
DR InterPro; IPR000152; EGF-type_Asp/Asn_hydroxyl_site.
DR InterPro; IPR018097; EGF_Ca-bd_CS.
DR InterPro; IPR009017; GFP.
DR InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR InterPro; IPR007110; Ig-like_dom.
DR InterPro; IPR036179; Ig-like_dom_sf.
DR InterPro; IPR013783; Ig-like_fold.
DR InterPro; IPR013098; Ig_I-set.
DR InterPro; IPR003599; Ig_sub.
DR InterPro; IPR003598; Ig_sub2.
DR PANTHER; PTHR12231; CTX-RELATED TYPE I TRANSMEMBRANE PROTEIN; 1.
DR PANTHER; PTHR12231:SF253; NEURAL CELL ADHESION MOLECULE; 1.
DR Pfam; PF12662; cEGF; 1.
DR Pfam; PF07645; EGF_CA; 3.
DR Pfam; PF07679; I-set; 7.
DR Pfam; PF13927; Ig_3; 3.
DR SMART; SM00181; EGF; 5.
DR SMART; SM00179; EGF_CA; 5.
DR SMART; SM00409; IG; 10.
DR SMART; SM00408; IGc2; 10.
DR SUPFAM; SSF57184; Growth factor receptor domain; 3.
DR SUPFAM; SSF48726; Immunoglobulin; 10.
DR PROSITE; PS00010; ASX_HYDROXYL; 2.
DR PROSITE; PS01186; EGF_2; 1.
DR PROSITE; PS50026; EGF_3; 2.
DR PROSITE; PS01187; EGF_CA; 3.
DR PROSITE; PS50835; IG_LIKE; 10.
PE 4: Predicted;
KW Disulfide bond {ECO:0000256|ARBA:ARBA00023157, ECO:0000256|PROSITE-
KW ProRule:PRU00076};
KW EGF-like domain {ECO:0000256|ARBA:ARBA00022536, ECO:0000256|PROSITE-
KW ProRule:PRU00076}; Repeat {ECO:0000256|ARBA:ARBA00022737}.
FT DOMAIN 21..111
FT /note="Ig-like"
FT /evidence="ECO:0000259|PROSITE:PS50835"
FT DOMAIN 116..203
FT /note="Ig-like"
FT /evidence="ECO:0000259|PROSITE:PS50835"
FT DOMAIN 207..297
FT /note="Ig-like"
FT /evidence="ECO:0000259|PROSITE:PS50835"
FT DOMAIN 302..385
FT /note="Ig-like"
FT /evidence="ECO:0000259|PROSITE:PS50835"
FT DOMAIN 390..477
FT /note="Ig-like"
FT /evidence="ECO:0000259|PROSITE:PS50835"
FT DOMAIN 481..568
FT /note="Ig-like"
FT /evidence="ECO:0000259|PROSITE:PS50835"
FT DOMAIN 573..660
FT /note="Ig-like"
FT /evidence="ECO:0000259|PROSITE:PS50835"
FT DOMAIN 665..751
FT /note="Ig-like"
FT /evidence="ECO:0000259|PROSITE:PS50835"
FT DOMAIN 828..912
FT /note="Ig-like"
FT /evidence="ECO:0000259|PROSITE:PS50835"
FT DOMAIN 948..1034
FT /note="Ig-like"
FT /evidence="ECO:0000259|PROSITE:PS50835"
FT DOMAIN 1350..1388
FT /note="EGF-like"
FT /evidence="ECO:0000259|PROSITE:PS50026"
FT DOMAIN 1422..1459
FT /note="EGF-like"
FT /evidence="ECO:0000259|PROSITE:PS50026"
FT DISULFID 1354..1364
FT /evidence="ECO:0000256|PROSITE-ProRule:PRU00076"
FT DISULFID 1426..1436
FT /evidence="ECO:0000256|PROSITE-ProRule:PRU00076"
SQ SEQUENCE 1616 AA; 179682 MW; 0CAD7956B8BBAF67 CRC64;
MQNLLTEYRL ISRVHLDYTA PQLDFSRNEQ QPHVITGRPI TLWCMVSGYP IPTIRWMKDG
YPISINKESG IRLIENEQGL EILEAKHEHA GIWMCEASNA AGKADYELTL DVWTLPTVSI
EPEDNVRPMD SVIMMQCQAT GNPEPSLSWT KDGQPLITST NGVRISSKGS RLDIPRLKQS
HVGEYTCTAV NEVGTASATV HVDVLVPPVI NRDNLEMSLR LPTAQTLTLI CDATGKPLPQ
IFWYVNNMII HETTSNVIIG EGGRYFQVKD VTLNDRGEYK CVASNIAGKD ELLYTVAIVQ
APKIVSDGNY QVIEGREAQI LCNVDGEPSP VITWQRNGIH IGTGMRYITE NKVLRIMDTR
SSDSGLYICV ATNEAGTAQQ AFTLEVFVVP RIITISPNES LIPVGKPFSL KCGVRGFPPP
EITWSLNGQV LGVGKTGYTI AEDGTLFVEK APKQARLTFK CIAKNNAGSD SKEYIIKVIS
PPVVMKEGIK TINATEGDPS LLVCEIEGEI PQIHWYKDGK PLILKPNIEL SPDRTQLKIH
HSKLHDEGMY SCVAVNPAGN ATQKQQLYVG VPPRITEKPR RIVVRSGHPA ELWCEAVGIP
KPHITWLKND KALLQTALDD FTDVLKSTAF FASVLSENSG VYTCKAENWA GTSYKDVDLV
VLIPPEIHPE RLNMTAKTGE TVMLTCNTTG VPEPVVSWMK MPNINIIGNE EKYQIYGTAL
HVRNVVPADD GFYHCVAKSN AGQAIGSRRL TVNDPRKDYK VIWVECDEFG QPIKTTFVPA
RGDVPDGDNN LLPWKQDPQD LPQNGTNGIL IRCLPESREI RRASLAIPRF IRSPRTQKVL
PGTVTDLHCS AIGRPKPRIV WMRNGAFLAG LSQPSAGHSI LRVKVESNDD LGDYVCLAQN
SVGSVSSIAT LFLDQAIEET DLFGYQCYTA SGRQTTEINF LSVQDDVPRV QTSPKQVFVN
VNEALLLNCQ VMSSPLTTMV QWTRNDVKLK DNSRTRILAN NSLHITKLLL SDRAVFKCIA
SNRYGKSYDD VKVIVRTSLA GVINKVKGII NGQRLKRETA LVSVKPKMVA NIVTMNANSI
FGEQGALAET LLGYMVVASP QLAFNPSQEN SLANVEFHRI TDYRFESGER MRVYQKGFGL
DGEYAQFEMV FNGQLPYFND ETYSWIDEAK VKMVQQEPDI IRGHGLAILR VGNQASIPWN
ESIVYDSSKG MNIGVGMSLT FKFAFRKTVY GDSKVSVMAR TESVRGICPV GYRIKDGFCT
DINECESTRE ICHERAHCVN TIGGYLCERN CPPGYKADLQ GDCADIDECT LGMHNCTSGV
LCVNRPGTFE CETSSCAKGY VQDSSGHCKD VDECAESLCG NLKCWNHLGS YSCICPTDFP
TDSNGRCEES QRNLTDLKLI RFDENLSVCE PGYYRIDGIC QDINECIFNL PCKYECENLE
GSYKCLCPEG YIVEQNNCTD INECLHDPCS KNDLCFNQLG SYECLTTPCP PDYHLEDQKC
MPNCQNCSNS SITIYMISIP KSIPPSTPLL RLTAYDHRSR VLRRTRFMMK SFSKFAKHIP
FTFKTKNGRA TLQNAESLLG AGTYKLAIRS ISKLPYIAGK LINDFIVFIS VSEYDF
//
